NIH-funded research R01 grant

Exploring how to help newly diagnosed HIV-positive men maintain low viral loads.

Official title: Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U

Funded at Whitman-Walker Institute, INC. · NIH-11046508 · Data updated 2026-11-12

This study is looking at the challenges that gay and bisexual men in the U.S. face after being newly diagnosed with HIV, to help find better ways to support them in keeping their viral load low and preventing the spread of the virus.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWhitman-Walker Institute, INC.
NIH-funded
Lab location1 site (Washington, United States)
Project startMarch 24, 2020
Project endFebruary 28, 2026
Funding year2025
Award (this year)$1,032,577
NIH project number5R01AI150502-06
Project IDNIH-11046508 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are gay and bisexual men who have recently been diagnosed with HIV.

Less likely to help

Patients who are not newly diagnosed with HIV or who do not identify as gay or bisexual men may not benefit from this research.

What this research studies

This research focuses on understanding the challenges faced by gay and bisexual men in the U.S. who are newly diagnosed with HIV. It aims to identify the structural, psychosocial, and behavioral factors that affect their ability to maintain viral load suppression, which is crucial for preventing the transmission of HIV. The study employs a Social Ecological Model to explore these factors and the implementation of effective messaging strategies like Treatment as Prevention (TasP) and Undetectable = Untransmittable (U=U). By examining these elements, the research seeks to inform better early intervention strategies for this population.

Why it matters

Potential benefit: If successful, this research could lead to improved health outcomes and reduced HIV transmission rates among newly diagnosed men.

How similar studies have gone: Previous research has shown success in addressing similar implementation barriers and improving health outcomes for HIV-positive populations.

Where this research is happening

  • Whitman-Walker Institute, INC.
    Washington, United States
    Active

Researchers

  • Principal investigator: Rendina, H. Jonathon — Whitman-Walker Institute, INC.
  • Study coordinator: Rendina, H. Jonathon

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.